Scientific work

Doç. Dr. Deniz Işık

94 publications. The source of the information is stated next to each publication.

Back to profile

  1. Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study

    Heliyon, 2024

    DOI 10.1016/j.heliyon.2024.e25029 PMID 38317875 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments: Analysis Based on Real-World Data

    Journal of Oncological Sciences, 2024

    DOI 10.37047/jos.2024-102164 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  3. The Clinical Significance of Fibrinogen-Like Protein 2 (FGL-2) Levels in Nonalcoholic Steatohepatitis

    Southern Clinics of Istanbul Eurasia, 2024

    DOI 10.14744/scie.2024.00187 Source: OpenAlex

  4. Association of New Inflammatory Markers Cumulative Inflammatory Index (ICC) and Mean Corpuscular Volume/Lymphocyte (MCVL) with Anti PD-1 Antibody Nivolumab Treatment Response in Metastatic Renal Cell Carcinoma

    Research Square, 2024

    DOI 10.21203/rs.3.rs-5381728/v1 Open-access full textSource: OpenAlex

  5. Prognostic and Molecular Characterization of Metastatic Transverse Colon Cancer: Insights From a Single-Center Retrospective Study

    Cureus, 2024

    DOI 10.7759/cureus.75046 PMID 39629291 Open-access full textSource: OpenAlex

  6. Association of Hepatitis-B virus infection status with survival and treatment response in non-small cell lung cancer patients on anti‐pd‐1/pd-l1 therapy

    Journal of Global Antimicrobial Resistance, 2024

    DOI 10.1016/j.jgar.2024.10.248 Open-access full textSource: OpenAlex

  7. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1287 PMID 37133230 22 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Onkoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1538 Open-access full textSource: OpenAlex

  10. Gastrointestinal Sistem Tümörleri-1

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1211 Open-access full textSource: OpenAlex

  11. Onkolojide Güncel Tedavi Yaklaşımları 1

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1606 Source: OpenAlex

  12. Jinekolojik Tümörler

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1215 Source: OpenAlex

  13. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience

    Cancer Investigation, 2021

    DOI 10.1080/07357907.2021.1933011 PMID 34014777 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  14. Adjuvant Chemotherapy in Elderly Patients with Early-stage Non-small Cell Lung Cancer

    Bezmialem Science, 2019

    DOI 10.14235/bas.galenos.2018.2631 Open-access full textSource: OpenAlex

  15. Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients

    Tumor Biology, 2016

    DOI 10.1007/s13277-015-4776-1 PMID 26753955 11 citations (Europe PMC) Source: OpenAlex

  16. Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma

    Clinical Colorectal Cancer, 2016

    DOI 10.1016/j.clcc.2016.04.013 PMID 27247089 17 citations (Europe PMC) Source: OpenAlex

  17. Three Different Chemotherapy Combinations with Concurrent Thoracic Radiation for Patients with Stage III Non-Small Cell Lung Cancer

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu348.10 Open-access full textSource: OpenAlex

  18. Akdağ G, Doğan A, Yıldırım S, Işık D ve ark. Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer. Cureus, 2024.

    Source: emseyhospital.com.tr profile page

  19. Kahraman S, Hizal M, Işık D ve ark. Activity of CDK4/6 Inhibitors and Parameters Affecting Survival in Elderly Patients. BMC Cancer, 2024. (Q2)

    Source: emseyhospital.com.tr profile page

  20. Yıldırım S, Doğan A, Akdağ G, Işık D ve ark. Lymphocyte-to-Albumin Ratio Predicts Survival in Metastatic NSCLC Patients. Cancers, 2024. (Q1)

    Source: emseyhospital.com.tr profile page

  21. Akdağ G, Alan Ö, Doğan A, Işık D ve ark. Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments. Journal of Oncological Sciences, 2024.

    Source: emseyhospital.com.tr profile page

  22. Altıntaş YE, Kınıkoğlu O, Yıldız A, Işık D ve ark. Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer. Medicina, 2024. (Q1)

    Source: emseyhospital.com.tr profile page

  23. Yıldırım S, Alan Ö, Yüksel YZ, Işık D ve ark. Prognostic Impact and Clinical Features of Spread Through Air Spaces in Operated Lung Cancer. Medicina, 2024. (Q1)

    Source: emseyhospital.com.tr profile page

  24. Işık D, Kınıkoğlu O, Akdağ G ve ark. Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Metastatic Renal Cell Carcinoma. Medicina, 2024. (Q1)

    Source: emseyhospital.com.tr profile page

  25. Gürler F, Tay F, Işık D ve ark. Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma. Cancer Medicine, 2024. (Q2)

    Source: emseyhospital.com.tr profile page

  26. Akdağ G, Yıldırım S, Doğan A, Işık D ve ark. Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2− Breast Cancer. Chemotherapy, 2024. (Q3)

    Source: emseyhospital.com.tr profile page

  27. Işık D, Koca D. XLOT Regimen Instead of FLOT Regimen in Gastric Cancer. Journal of Cancer Research and Therapeutics, 2023.

    Source: emseyhospital.com.tr profile page

  28. Kahraman S, Urul E, Işık D ve ark. Treatment Efficacy of Ribociclib or Palbociclib Plus Letrozole in Metastatic Breast Cancer. Future Oncology, 2023.

    Source: emseyhospital.com.tr profile page

  29. Karaçin C, Işık D ve ark. Efficacy of Subsequent Treatments in Patients with Hormone-Positive Advanced Breast Cancer. BMC Cancer, 2023.

    Source: emseyhospital.com.tr profile page

  30. Bahçeci A, Paydaş S, Işık D ve ark. Efficacy and Safety of Trastuzumab Emtansine in HER2 Positive Metastatic Breast Cancer. Cancer Investigation, 2021.

    Source: emseyhospital.com.tr profile page

  31. Bahçeci A, Kötek SA, Işık D. The Prognostic Values of Prognostic Nutritional Index in Extensive-Stage Small Cell Lung Cancer. Anti-Cancer Drugs, 2021.

    Source: emseyhospital.com.tr profile page

  32. Özçelik M, Korkmaz T, Odabaş H, Işık D ve ark. Comparison of Chemotherapy Regimens in Inoperable Stage III Non-Small Cell Lung Cancer. Tumor Biology, 2016.

    Source: emseyhospital.com.tr profile page

  33. Aydın D, Bilici A, Yavuzer D, Işık D ve ark. Prognostic Significance of ADAM17 Expression in Gastric Cancer. Clinical & Translational Oncology, 2015.

    Source: emseyhospital.com.tr profile page

  34. Özçelik M, Odabaş H, Işık D ve ark. Capecitabine Plus Bevacizumab Combination in Elderly Metastatic Colorectal Cancer Patients. Clinical & Translational Oncology, 2015.

    Source: emseyhospital.com.tr profile page

  35. Efficacy and Safety of CDK4/6 Inhibitor Therapy in Patients Aged 70 and Older with Metastatic Breast Cancer: A Retrospective Single Center Analysis. Southern Clinics of Istanbul Eurasia, 2025.

    Source: emseyhospital.com.tr profile page

  36. The Prevalence and Prognostic Relevance of ABO/Rh Blood Groups in Metastatic Breast Cancer Patients Undergoing CDK4/6 Inhibitor Therapy. Eurasian Journal of Medical Investigation, 2024.

    Source: emseyhospital.com.tr profile page

  37. Factors Affecting Recurrence in Transverse Colon Tumors: A Single-Center Study. Southern Clinics of Istanbul Eurasia, 2024.

    Source: emseyhospital.com.tr profile page

  38. Onkolojide Güncel Tedavi Yaklaşımları (2019) – Tiroid Kanserlerinde Tirozin Kinaz İnhibitör Tedavisi

    Source: emseyhospital.com.tr profile page

  39. Onkoloji (2018) – Jinekolojik Kanserler

    Source: emseyhospital.com.tr profile page

  40. Multidisipliner Baş Boyun Kanserleri Kongresi (2025)

    Source: emseyhospital.com.tr profile page

  41. Meme Kanseri Sempozyumu (2025)

    Source: emseyhospital.com.tr profile page

  42. Onkolojide Yenilikler Sempozyumu (2024)

    Source: emseyhospital.com.tr profile page

  43. Onkolojide Yenilikler Sempozyumu (2023)

    Source: emseyhospital.com.tr profile page

  44. Türk Tıbbi Onkoloji Kongresi (2023)

    Source: emseyhospital.com.tr profile page